Skip to main content
. 2025 Jul 11;11(3):365–386. doi: 10.1007/s41030-025-00303-4

Table 1.

CF survival and mortality literature review—studies reporting longitudinal median survival age among people with CF, by country (n = 10 studies)

Source Study years Population description Ages Study no. Sub-group Age of survival median (95% CI) Longitudinal trend direction
United States
FitzSimmons 1994 and FitzSimmons 1993 [47, 48]a, b 1969–1990 U.S. CF Foundation Patient Registry All ages 7795 1969 14
17,857 1990 27.6
Kulich 2003 [50] 1985–1999 U.S. CF Foundation Patient Registry All ages 31,012 1985, Males 34.5
1999, Males 37.1
1985, Females 31.5
1999, Females 34.9
Jackson 2011 [46] a 1986–2008 U.S. CF Foundation Patient Registry patients with death records All ages 8849 1986 26.7 (25.3–28.3)
2008 37.4 (35.0–40.1)
Stephenson 2017 [45] c 1990–2013 U.S. CF Foundation Patient Registry All ages 32,699 2009–2013, Includes post-transplant follow-up 40.6 (39.1–41.8) ↑ (data in figure only)
2009–2013, Censoring at transplant 44.0
Ostrenga 2023 [49] a, d 1986–2017 U.S. CF Foundation Patient Registry linked to the National Death Index All ages 30,788 1986–1990 29.7
2013–2017 45.8
Canada
Corey 1996 [54] 1970–1989 Canadian Patient Data Registry All ages 3795 1970–1989, Males 29.5
1970–1974, Males 26.6
1985–1989, Males 36.7
1970–1989, Females 21.3
1970–1974, Females 19.7
1985–1989, Females 27.8
Stephenson 2015 [53] c 1990–2012 Canadian CF Registry All ages 5787 1990 31.9 (28.3–35.2)
2008–2012 49.7 (46.1–52.2)
Stephenson 2017 [45] c 1990–2013 Canadian CF Registry All ages 4662 2009–2013, Includes post-transplant follow-up 50.9 (50.5–52.2) ↑ (data in figure only)
2009–2013, Censoring at transplant 57.1
France
Bellis 2007 [52] a 1994–2003 Observatoire National de la Mucoviscidose in mainland France and Reunion Island All ages n/s 1994–1996 28.1
2001–2003 36.4
Ireland
Jackson 2011 [46] a 1986–2008 CF Registry of Ireland patients with death records All ages 421 1986 20.1 (13.0–34.4)
2008 35.2 (24.5-N/A)
Australia
Ruseckaite 2022 [51] a 2005–2020 Australian CF Data Registry All ages 4601 2005–2009 48.9 (44.7–53.5)
2016–2020 56.3 (53.0–60.4)
Japan
Kozawa 2023 [55] b 1994–2022 National epidemiological survey and Japan CF Registry All ages 132 2012 18.8 (16.6–21.1)
2022 25.2 (18.7–31.7)

CF cystic fibrosis, CI confidence interval, N/A not available, N/S not stated, U.S. United States; ↑ = increasing over time; ↓ = decreasing over time

aData also reported for additional years; the first and last years of data available are presented in this table

bMedian survival age also reported by gender (males, females)

cData also reported for additional years in figure only

dMedian survival age also reported for CFFPR standard reporting with no linkage to NDI